Literature DB >> 26554254

Downregulation of MicroRNA-1 is Associated with Poor Prognosis in Hepatocellular Carcinoma.

Xuanyi Wang, Yuxiang Huang, Haiwen Zhuang, Yayun Qian, Qiu Zhao, Lin Yang, Hao Gu, Jue Chen, Renhua Guo, Yanqing Liu.   

Abstract

BACKGROUND: The relationship between microRNA-1 (miR-1) expression and prognosis has not been reported in hepatocellular carcinoma (HCC). The present study aimed to explore the clinicopathological significance and the prognostic role of miR-1 in HCC.
METHODS: The expression levels of miR-1 were quantified using real-time quantitative PCR (q-PCR) in 40 surgically resected HCC samples and matched adjacent non-cancerous tissues.
RESULTS: MiR-1 expression was significantly downregulated in HCC compared with matched non-cancerous tissues. Aberrant miR-1 expression was significantly correlated with gender, expression of hepatitis B virus surface antigen (HBsAg), tumor differentiation, vein invasion, and TNM stage. Patients with low expression of miR-1 had significantly reduced overall survival compared with patients with high expression of miR-1 (p = 0.04).The multivariate Cox regression analysis indicated that miR-1 expression (HR = 2.79; p = 0.005), gender (HR = 0.087; p = 0.005), vein invasion (HR = 0.172; p = 0.007), and TNM stage (HR = 3.421; p = 0.001) were independent prognostic factors for overall survival.
CONCLUSIONS: Low miR-1 expression is associated with shortened survival time. MiR-1 may act as a potential prognostic biomarker for HCC patients.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26554254     DOI: 10.7754/clin.lab.2015.150319

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  5 in total

1.  miR-1 suppresses the proliferation and promotes the apoptosis of esophageal carcinoma cells by targeting Src.

Authors:  Zhicong Liao; Xiaojun Wang; Hongwei Liang; Ao Yu; Uzair Ur Rehman; Qian Fan; Yue Hu; Chen Wang; Zhen Zhou; Tao Wang
Journal:  Cancer Med       Date:  2017-10-16       Impact factor: 4.452

2.  Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis.

Authors:  Yue Zhang; Chao Wei; Cong-Cong Guo; Rong-Xiu Bi; Jin Xie; Dong-Hui Guan; Chuan-Hua Yang; Yue-Hua Jiang
Journal:  Oncotarget       Date:  2017-09-14

3.  miR-1 inhibits progression of high-risk papillomavirus-associated human cervical cancer by targeting G6PD.

Authors:  Tao Hu; Ye-Fei Chang; Zhangang Xiao; Rui Mao; Jun Tong; Bo Chen; Guang-Cai Liu; Ying Hong; Hong-Lan Chen; Shu-Yi Kong; Yan-Mei Huang; Yan-Bin Xiyang; Hua Jin
Journal:  Oncotarget       Date:  2016-12-27

4.  miR-1-3p suppresses proliferation of hepatocellular carcinoma through targeting SOX9.

Authors:  Hao Zhang; Zhenya Zhang; Lili Gao; Zhengdong Qiao; Minghua Yu; Bo Yu; Tao Yang
Journal:  Onco Targets Ther       Date:  2019-03-22       Impact factor: 4.147

5.  MicroRNA-1 suppresses proliferation, migration and invasion by targeting Notch2 in esophageal squamous cell carcinoma.

Authors:  Wenzhi Liu; Mengkao Li; Xiangming Chen; Shan Zhu; Hailong Shi; Dawei Zhang; Cheng Cheng; Baosheng Li
Journal:  Sci Rep       Date:  2018-03-26       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.